We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Employment Tribunal decision.
SGLT2 inhibitor treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses and ketone levels measured, preferably in blood rather than urine. Treatment may be restarted when the ketone values are normal...
People with diabetes using the Accu-Chek Insight insulin pump system should check how they operate and wear the medical device to reduce the risk of an unwanted dose of insulin
Manufactured by Roche Diabetes Care - inadequately detailed handling instructions of the 'Key Lock' function of the pump may lead to unintentional operation, which could result in rapid and severe deterioration of health e.g. hypoglycaemia or diabetic ketoacidosis.
Canagliflozin may increase the risk of lower-limb amputation (mainly toes) in patients with type 2 diabetes. Evidence does not show an increased risk for dapagliflozin and empagliflozin, but the risk may be a class effect. Preventive foot care is important...
(Medtronic) Risk due to incorrect selection and delivery of bolus amount. (MDA/2014/019)
There have been reports of acute pancreatitis associated with drugs in the dipeptidylpeptidase-4 (DPP-4) inhibitor class of antidiabetic agents (‘gliptins’).
Employment Appeal Tribunal judgment of Judge Clarke on 23 September 2021.
University spin-out - supported by UK Research and Innovation funding - acquired to develop 'groundbreaking' treatment for diabetes.
People with diabetes are being asked to check whether they have certain batches of GlucaGen® HypoKits used for the emergency treatment of severe low blood glucose (hypoglycaemia).
People with underlying conditions including cancer, diabetes and heart disease are encouraged to come forward for a COVID-19 vaccine by leading UK health charities.
First published during the 2019 to 2022 Johnson Conservative government
Manufactured by Roche Diabetes Care – Replacement and update to MDA/2015/029 with new instructions to improve battery lifetime and prevent unexpected pump shut down or rapid battery depletion.
Advice to Rt Hon Theresa May, former Prime Minister, on business appointments taken up after Crown service
People with diabetes who use particular blood glucose test strips should stop using them and seek an alternative as soon as possible says the Medicines and Healthcare products Regulatory Agency (MHRA). This follows a manufacturing fault which could lead to...
A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
Care needed to minimise risk of error, including training for patients.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).